@ARTICLE{
author={van Dussen Laura,Zimran An,Akkerman EM,Aerts JMFG,Petakov Milan S,Elstein Deborah,Rosenbaum H,Aviezer David,Brill-Almon Einat,Chertkoff Raul,Maas M,Hollak CEM},
year={2013},
title={Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={50},
number={3},
pages={206-211},
document_type={Article},
} 

@ARTICLE{
author={Elstein Deborah,Foldes Joseph A,Zahrieh David,Cohn Gabriel M,Djordjevic Maja S,Brutaru Costin,Zimran An},
year={2011},
title={Significant, Continuous Improvement in Bone Mineral Density (Bmd) Among Type 1 Gaucher Disease Patients Treated with Velaglucerase Alfa: 69-Month Experience, Including Dose Reduction},
journal={JOURNAL OF INHERITED METABOLIC DISEASE},
volume={34},
number={},
pages={S223-S223},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Elstein Deborah,Foldes Joseph A,Zahrieh David,Cohn Gabriel M,Djordjevic Maja S,Brutaru Costin,Zimran An},
year={2011},
title={Significant, continuous improvement in Bone Mineral Density (BMD) among type 1 Gaucher disease patients treated with Velaglucerase Alfa: 69-month experience, including dose reduction},
journal={MOLECULAR GENETICS AND METABOLISM},
volume={102},
number={2},
pages={S17-S18},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Elstein Deborah,Cohn Gabriel M,Wang N,Djordjevic Maja S,Brutaru Costin,Zimran An},
year={2011},
title={Early achievement and maintenance of the therapeutic goals using velaglucerase alfa in type 1 Gaucher disease},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={46},
number={1},
pages={119-123},
document_type={Article},
}